VIMMRIXEQ Trademark

Trademark Overview


On Friday, December 1, 2023, a trademark application was filed for VIMMRIXEQ with the United States Patent and Trademark Office. The USPTO has given the VIMMRIXEQ trademark a serial number of 98294735. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, October 29, 2024. This trademark is owned by GlaxoSmithKline Biologicals SA. The VIMMRIXEQ trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
vimmrixeq

General Information


Serial Number98294735
Word MarkVIMMRIXEQ
Filing DateFriday, December 1, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, October 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 29, 2024

Trademark Statements


Goods and ServicesVaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 1, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxoSmithKline Biologicals SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Trademark Events


Event DateEvent Description
Sunday, February 25, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 1, 2023NEW APPLICATION ENTERED
Saturday, June 29, 2024LETTER OF SUSPENSION E-MAILED
Saturday, June 29, 2024SUSPENSION LETTER WRITTEN
Saturday, June 29, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, June 29, 2024ASSIGNED TO EXAMINER
Tuesday, September 10, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 10, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 10, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, September 11, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 12, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, September 19, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, October 9, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 29, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 29, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED